The first GenMark Diagnostics trade was made in Q1 2016.
Since then Jim Simons bought shares seven more times and sold shares on six occasions. The investor completely sold their stake between Q4 2020 and Q2 2021.
Avg closing price
Price range
Sold -1.01 Million shares
Q2 2021
Avg closing price
$23.98
Price range
$23.89
-
$24.04
Sold 30.8% shares (-450 Thousand shares)
Q1 2021
Avg closing price
$18.59
Price range
$13.42
-
$24.17
Sold 46.1% shares (-1.25 Million shares)
Q4 2020
Avg closing price
$13.25
Price range
$11.09
-
$15.38
Increased shares by 1.2% (+33.1 Thousand shares)
Q3 2020
Avg closing price
$15.28
Price range
$11.24
-
$19.10
Increased shares by 359.9% (+2.09 Million shares)
Q2 2020
Avg closing price
$10.16
Price range
$4.19
-
$14.71
Sold 18.7% shares (-134 Thousand shares)
Q1 2020
Avg closing price
$4.69
Price range
$3.49
-
$6.00
Increased shares by 28.7% (+159 Thousand shares)
Q4 2019
Avg closing price
$5.52
Price range
$4.76
-
$5.96
Increased shares by 63.8% (+216 Thousand shares)
Q3 2019
Avg closing price
$6.24
Price range
$5.74
-
$6.73
Increased shares by 156.6% (+207 Thousand shares)
Q2 2019